Empirical Financial Services LLC d.b.a. Empirical Wealth Management Boosts Stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 159.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 65,414 shares of the company’s stock after purchasing an additional 40,243 shares during the quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Aveanna Healthcare were worth $355,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of the business. Price T Rowe Associates Inc. MD raised its stake in shares of Aveanna Healthcare by 5.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,699 shares of the company’s stock worth $246,000 after purchasing an additional 2,649 shares during the last quarter. Rhumbline Advisers raised its stake in shares of Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock worth $410,000 after purchasing an additional 2,918 shares during the last quarter. Bank of New York Mellon Corp increased its position in Aveanna Healthcare by 4.2% during the first quarter. Bank of New York Mellon Corp now owns 114,881 shares of the company’s stock valued at $623,000 after acquiring an additional 4,655 shares during the last quarter. Tower Research Capital LLC TRC increased its position in Aveanna Healthcare by 662.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock valued at $36,000 after acquiring an additional 6,854 shares during the last quarter. Finally, BNP Paribas Financial Markets purchased a new stake in Aveanna Healthcare during the fourth quarter valued at $35,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Robert M. Williams, Jr. sold 1,560,700 shares of the company’s stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00. Following the completion of the transaction, the insider owned 29,640,756 shares of the company’s stock, valued at $158,874,452.16. This represents a 5.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Patrick A. Cunningham sold 18,500 shares of the company’s stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $4.93, for a total value of $91,205.00. Following the completion of the transaction, the insider directly owned 327,869 shares of the company’s stock, valued at approximately $1,616,394.17. This trade represents a 5.34% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 7,115,345 shares of company stock valued at $37,838,057. 7.80% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. UBS Group upped their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a research report on Friday, May 9th. Truist Financial reduced their price objective on Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating for the company in a research report on Wednesday, July 16th. Jefferies Financial Group upgraded Aveanna Healthcare from a “hold” rating to a “buy” rating and reduced their price objective for the company from $6.25 to $6.00 in a research report on Monday, July 21st. Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 27th. Finally, Barclays started coverage on Aveanna Healthcare in a research report on Wednesday, July 2nd. They issued an “equal weight” rating and a $5.50 price target for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Aveanna Healthcare has a consensus rating of “Hold” and an average target price of $5.25.

Aveanna Healthcare Stock Down 5.8%

Shares of AVAH opened at $3.74 on Friday. The business has a 50-day simple moving average of $4.67 and a two-hundred day simple moving average of $4.80. The stock has a market cap of $729.64 million, a price-to-earnings ratio of 187.00 and a beta of 1.96. Aveanna Healthcare Holdings Inc. has a 52 week low of $2.61 and a 52 week high of $6.19.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.